Literature DB >> 30058754

STUB1 polyadenylation signal variant AACAAA does not affect polyadenylation but decreases STUB1 translation causing SCAR16.

Burcu Turkgenc1, Burcin Sanlidag2, Amber Eker3, Aslı Giray4, Ozgur Kutuk5, Cengiz Yakicier6, Aslıhan Tolun7, Sehime G Temel8,9,10.   

Abstract

We present three siblings afflicted with a disease characterized by cerebellar ataxia, cerebellar atrophy, pyramidal tract damage with increased lower limb tendon reflexes, and onset of 31 to 57 years, which is not typical for a known disease. In a region of shared homozygosity in patients, exome sequencing revealed novel homozygous c.*240T > C variant in the 3'UTR of STUB1, the gene responsible for autosomal recessive spinocerebellar ataxia 16 (SCAR16). In other genes, such an alteration of the evolutionarily highly conserved polyadenylation signal from AATAAA to AACAAA is known to highly impair polyadenylation. In contrast, RNA sequencing and quantification revealed that neither polyadenylation nor stability of STUB1 mRNA is affected. In silico analysis predicted that the secondary structure of the mRNA is altered. We propose that this change underlies the extremely low amounts of the encoded protein in patient leukocytes.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  3′UTR; SCAR16; STUB1; cerebellar atrophy; polyadenylation

Mesh:

Substances:

Year:  2018        PMID: 30058754     DOI: 10.1002/humu.23601

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  7 in total

Review 1.  Spinocerebellar ataxia type 48: last but not least.

Authors:  Giovanna De Michele; Daniele Galatolo; Melissa Barghigiani; Diletta Dello Iacovo; Rosanna Trovato; Alessandra Tessa; Elena Salvatore; Alessandro Filla; Giuseppe De Michele; Filippo M Santorelli
Journal:  Neurol Sci       Date:  2020-04-27       Impact factor: 3.307

2.  Extending the Phenotypic Spectrum Associated with STUB1 Mutations: A Case of Dystonia.

Authors:  Diana A Olszewska; Justin A Kinsella
Journal:  Mov Disord Clin Pract       Date:  2020-03-09

3.  Changes in protein function underlie the disease spectrum in patients with CHIP mutations.

Authors:  Sabrina C Madrigal; Zipporah McNeil; Rebekah Sanchez-Hodge; Chang-He Shi; Cam Patterson; Kenneth Matthew Scaglione; Jonathan C Schisler
Journal:  J Biol Chem       Date:  2019-10-16       Impact factor: 5.157

Review 4.  CHIP as a therapeutic target for neurological diseases.

Authors:  Shuo Zhang; Zheng-Wei Hu; Cheng-Yuan Mao; Chang-He Shi; Yu-Ming Xu
Journal:  Cell Death Dis       Date:  2020-09-09       Impact factor: 8.469

5.  Carboxyl Terminus of Hsp70-Interacting Protein Is Increased in Serum and Cerebrospinal Fluid of Patients With Spinocerebellar Ataxia Type 3.

Authors:  Zheng-Wei Hu; Zhi-Hua Yang; Shuo Zhang; Yu-Tao Liu; Jing Yang; Yan-Lin Wang; Cheng-Yuan Mao; Qi-Meng Zhang; Chang-He Shi; Yu-Ming Xu
Journal:  Front Neurol       Date:  2019-10-15       Impact factor: 4.003

6.  Heterozygous STUB1 missense variants cause ataxia, cognitive decline, and STUB1 mislocalization.

Authors:  Dong-Hui Chen; Caitlin Latimer; Mayumi Yagi; Mesaki Kenneth Ndugga-Kabuye; Elyana Heigham; Suman Jayadev; James S Meabon; Christopher M Gomez; C Dirk Keene; David G Cook; Wendy H Raskind; Thomas D Bird
Journal:  Neurol Genet       Date:  2020-02-10

Review 7.  C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside.

Authors:  Sivakami Mylvaganam; Rebecca Earnshaw; Gregory Heymann; Suneil K Kalia; Lorraine V Kalia
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.